DSM265 is having promising trials in the treatment of: (A) Tuberculosis, (B) Leprosy, (C) Malaria, (D) Trypanosoma
Answer is C. DSM265 an inhibitor of dihydroorotate dehydrogenase is effective in single oral dose both in prophylaxis and treatment against P.falciparum. Proposed to give as a single dose. Ref:www.thelancet.comjournals.